NextBio has launched NextBio Clinical platform to aid translational research and biomarker discovery. The curated genomic, molecular and clinical profiles from individual patients are added to the platform's existing repository of ...
Tags: platform for drug companies, Clinical platform, NextBio
Lixte Biotechnology, a cancer drug discovery company, has received a notice of allowance from the USPTO for its histone deacetylase inhibitor (HDACi), LB-201, and other structural homologs. Lixte founder and president John Kovach said ...
Tags: USPTO, cancer treatment, clinical technology, pharmaceutical product